Humana Inc: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 16, 2023 and accepted by EDGAR at Feb 16, 2023, 15:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $92.87bn | us-gaap:Revenues |
| Selling, general and administrative | 12 months2022-01-01 to 2022-12-31 | $12.67bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $3.80bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | $401.0m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $762.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $2.81bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $22.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $22.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 127,094,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $4.59bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $1.12bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-01-01 to 2022-12-31 | $98.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $2.10bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $5.06bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $26.18bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $43.05bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $17.18bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $27.68bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $9.03bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-12-31 | $2.09bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2022-12-31 | $15.31bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000049071-23-000011. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.